REFERENCIAS BIBLIOGRÁFICAS PACLITAXEL

1. NIOSH Alert: Preventing occupational exposures to antineoplastic and other hazardous drugs in healthcare settings. 2004. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2004-165.

2. OSHA Technical Manual, TED 1-0.15A, Section VI: Chapter 2. Controlling Occupational Exposure to Hazardous Drugs. OSHA, 1999. Available at: http:// www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html.

3. American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health-Syst Pharm. 2006;63:1172-1193.

4. Polovich M, White JM, Kelleher LO, eds. 2005. Chemotherapy and biotherapy guidelines and recommendations for practice. 2nd ed. Pittsburgh, PA: Oncology Nursing Society.

M.S.: 1.0043.0899

Farm. Resp.: Dra. Sonia Albano Badaro . CRF-SP 19.258

USO RESTRITO A HOSPITAIS.

VENDA SOB PRESCRICAO MÉDICA.

Esta bula foi atualizada conforme Bula Padrão aprovada pela ANVISA em 12/01/2011.

EUROFARMA LABORATÓRIO LTDA

Av. Vereador José Diniz, 3.465 – São Paulo – SP

CNPJ:61.190.096/0001-92

Indústria Brasileira